Abstract
Leigh syndrome (LS) or subacute necrotizing encephalomyelopathy is a progressive, lethal, mitochondrial disease mostly presenting in childhood. We report a 36-year-old African male presenting to the Emergency Department with a 6-month history of progressive dysarthria. Examination also showed oculomotor limitations for downgaze and convergence, mild right hemiparesis with Babinski sign, and absent lower limb tendon reflexes. He revealed he was presenting mild walking difficulties since the age of 25. Family history was unremarkable. A brain magnetic resonance showed diffuse white matter lesions without enhancing around the third ventricle, in the medulla oblongata, and bilaterally to the caudate and the putamen. Polymerase-chain-reaction amplification of the mitochondrial genes, followed by direct sequencing, found a 10191T>C variant related to LS. To now, only 8 late-onset patients share the same pathogenic variant.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Leigh syndrome (LS) or subacute necrotizing encephalomyelopathy is a progressive neurological disease with specific neuropathological lesions to the brainstem and basal ganglia. Birth prevalence is approximately 1 in 36,000. Symptom onset occurs within the first 12 months, but in rare cases, the disease onset occurs during adolescence or early adult life.
Leigh syndrome can be caused by variants in one of more than 85 different genes. Recurrent, structural subunit mutations including m.10158T>C,12 m.10191T>C,13 and m.10197G>A14 in the MTND3 gene; m.12706T>C,15 m.13513G>A,16 and m.13514A>G17 in the MTND5 gene, and m.14459G>A18 and m.14487T>C19 in the MTND6 gene all contribute to the broad clinical spectrum of disease phenotypes. One such mutation, m.10191T>C in MTND3 variant causes a mitochondrial complex I deficiency NADH: ubiquinone oxidoreductase, the largest of the five multimeric enzyme complexes of the oxidative phosphorylation system, comprising seven mitochondrial-encoded subunits and at least 38 nuclear-encoded subunits. The NADH transfer electrons to ubiquinone using this complex via a series of protein-coupled redox centers and the translocation of protons across the inner mitochondrial membrane, contributing to the synthesis of adenosine triphosphate. The alteration of this metabolic pathway results in variable phenotypes from organ-specific to multisystem disease [1].
Here, we describe a patient with an alteration of this metabolic pathway and a review of similar cases from the literature.
Case Presentation
A 36-year-old African male presenting to the Emergency Department after falling over. On neurological examination, he showed ideomotor slowness and mild spastic gait due to a mild right hemiparesis with Babinski sign. He also showed dysarthria, down-gaze impairment, and loss of convergence. Temperature and pain sensation in the right leg was reduced. Tendon reflexes were reduced at the upper and absent at the lower limbs. There was no muscle atrophy or fasciculations. His relatives later revealed a progressive walking impairment with falls since the age of 25, as well as speech difficulties in the last 3 years. The family history was mute. He was a metal worker and denied any medication or abuse.
Investigations
At first, the clinical evaluation depicted a slowly progressive disease with dysarthria, gaze palsy, right hemiparesis with Babinski sign, and walking difficulties. This picture may well suggest brainstem damage. Secondly, features such as diffuse tendon hypo/areflexia and superficial hypoesthesia of the right leg would suggest a concurrent involvement of the peripheral nervous system.
In the Emergency Department, a computerized tomography (CT) scan of the head showed discrete hypodense areas around the third ventricle, the lenticular nuclei, and the right caudate nucleus. Initially, we considered it an infective/inflammatory or demyelinating disease. The patient then underwent magnetic resonance imaging (MRI) (Fig. 1), showing multiple white matter hyperintense lesions on fluid-attenuated inversion recovery (FLAIR) sequences. These lesions appeared to be symmetrically located: around the third ventricle, to the anterior putamen and the head of caudate nuclei (restricted on diffusion-weighted imaging or DWI), and in the posterior part of the caudate nuclei and medulla oblongata (not restricted to DWI). No lesions displayed gadolinium enhancement. Spectroscopy documented alteration with increased lactate, choline, and creatine and reduced n-acetyl-aspartate peaks, suggesting a mitochondrial disorder. Serum creatine kinase level was slightly increased (359 U/L; normal range: 38–174). Unremarkable blood tests included erythrocyte sedimentation rate, C-reactive protein, lupus anti-coagulant, anti-double strand deoxyribonucleic acid and extractable-nuclear antibodies, vitamin B12 and folate, Treponema, Borrelia, tuberculosis, and human immunodeficient virus, anti-oligodendrocyte myelinated glycoprotein and anti-aquaporin4 antibodies. Cerebrospinal fluid (CSF) analysis showed no cells, normal protein (39 mg/dL) and glucose (84 mg/dL), slightly increased lactate (2.1 mMol/l if compared to the serum value of 0.9), and no oligoclonal bands. CSF rapid bacterial and viral antigens were negative. Nerve conduction studies showed mild sensitive axonal neuropathy at the lower limbs. Optic fundoscopy and visually evoked potentials were normal. We excluded a covert alcohol abuse, denied by the patient, with normal carbohydrate-deficient transferrin (and normal mammillary bodies on MRI). Serum levels of lead, copper, and manganese were normal.
Magnetic resonance imaging (MRI) showed A–C axial-sagittal fluid-attenuated inversion recovery (FLAIR) sequences with bilateral lesions around the third ventricle, to the anterior putamen and the head of caudate nuclei, and in the posterior part of the caudate nuclei and medulla oblongata (blue arrows); D, E axial-sagittal diffusion-weighted imaging (DWI) showing bilateral restriction to the anterior putamen and the head of caudate nuclei (not to the posterior part of the caudate nuclei) (red arrows; E–G) axial-sagittal T1 sequences after gadolinium revealed no contrast enhancement
Meanwhile, the patient’s respiratory function worsened, and he underwent a tracheostomy. We decided to focus on the MRI findings and considered a biotin-thiamine-responsive basal ganglia disease, supplementing thiamine and biotin with no improvement [2]. There was no history of carbon monoxide or methanol intoxication, and normal serum ceruloplasmin was against Wilson’s disease. We then searched for mitochondrial disorders [3, 4] and performed a muscle biopsy on the left quadriceps femoris showing mild, nonspecific myopathic changes with no “ragged red” fibers. Subsequently, we performed genetic testing for point mutations in the genes of the mitochondrial oxidative phosphorylation complex, which was negative. Finally, PCR amplification of the mitochondrial genes, followed by direct sequencing, found a 10191T>C variant, which is reported as pathogenic for LS [5, 6]. To identify any point mutations in the mitochondrial DNA, a Sanger sequencing was carried out starting from DNA extracted from a muscle biopsy. The m.10191T>C mutation was subsequently studied by restriction fragment length polymorphism analysis to identify the percentage of heteroplasmy in muscle and lymphocytes, resulting respectively 45% and 8%.
Clinical Course and Management
The patient started with acetylcarnitine 1500 mg and ubidecarenone 50 mg daily, then was transferred to the rehabilitation unit. His respiratory function improved and the tracheostomy was removed. He is still alive 2 years after diagnosis.
Discussion
Adult-onset LS (later than 15 years old) has been reported extremely rarely with these cardinal features: seizures, ataxia/dystonia, external ophthalmoplegia, and spastic weakness. Serum and CSF may reveal lactic acidosis [4, 6-10]. Suspicion relies mainly on MRI/spectroscopy findings: hallmarks are bilateral, symmetric necrotizing lesions in the basal ganglia, thalamus, brainstem, and spinal cord, with spared mammillary bodies [11, 12]. Spectroscopy might be of help in differentiating Leigh syndrome from a range of other mitochondrial diseases, such as ophthalmoplegia and Kearns-Sayre syndrome, showing a lack of lactate in brain tissues appearing normal on MRI. Deficits in pyruvate dehydrogenase complex and mitochondrial respiratory chain complexes I, II, and IV are related to necrotizing lesions on T2-weighted MRI and FLAIR [12]. It is not known to what extent the degree of heteroplasmy correlates with the severity of the disease, as far as possible in relation to the case presented it is possible to say that the absence of symptoms till adulthood could be correlated with the low degree of heteroplasmy found (45% muscle and 8% % lymphocytes).
Conclusion
LS is genetically heterogeneous since pathogenic mutations were found in over 85 genes [3]. Only 8 adult-onset cases share the same mutation as ours (Table 1). The majority presented with seizures (7 patients), myoclonus (3 patients), and optic atrophy (2 patients). These features were absent in our patient who showed a predominant respiratory involvement and failure (Table 1). MRI was confirmed as the most informative investigation in the cohort, while muscle biopsy was not.
Data Availability
Data are available from the author’s mail dott.elia.cipriano@gmail.com.
Code Availability
Not applicable.
References
Nesbitt V, Morrison PJ, Crushell E, Donnelly DE, Alston CL, He L, McFarland R, Taylor RW. The clinical spectrum of the m.10191T>C mutation in complex I-deficient Leigh syndrome. Dev Med Child Neurol. 54(6):500–6.
Tabarki B, Al-Shafi S, Al-Shahwan S, Azmat Z, Al-Hashem A, Al-Adwani N, et al. Biotin-responsive basal ganglia disease revisited: clinical, radiologic, and genetic findings. Neurology. 2013;80(3):261–7.
Baertling F, Rodenburg RJ, Schaper J, Smeitink JA, Koopman WJH, Mayatepek E, et al. A guide to diagnosis and treatment of Leigh syndrome. J Neurol Neurosurg Psychiatry. 2014;85(3):257–65.
Finsterer J. Leigh and Leigh-like syndrome in children and adults. Pediatr Neurol. 2008;39(4):223–35.
Levy RJ, Ríos PG, Akman HO, Sciacco M, Vivo DCD, DiMauro S. Long survival in patients with leigh syndrome and the m.10191T>C mutation in MT-ND3: a case report and review of the literature. J Child Neurol. 2014;29(10):NP105–10.
Li TR, Wang Q, Liu MM, Lv RJ. A Chinese family with adult-onset Leigh-like syndrome caused by the heteroplasmic m.10191T>C mutation in the mitochondrial MTND3 gene. Front Neurol. 2019;10:347.
Taylor RW, Singh-Kler R, Hayes CM, Smith PE, Turnbull DM. Progressive mitochondrial disease resulting from a novel missense mutation in the mitochondrial DNA ND3 gene. Ann Neurol. 2001;50(1):104–7.
Malfatti E, Bugiani M, Invernizzi F, de Souza CFM, Farina L, Carrara F, et al. Novel mutations of ND genes in complex I deficiency associated with mitochondrial encephalopathy. Brain. 2007;130(Pt 7):1894–904.
Yan-ping W, Li-ying C, Bin P. Two cases of mitochondrial encephalomyopathy caused by ND3 gene mutation. J Brain Nervous Dis. 2016;24:626–30.
Wei Y, Cui L, Peng B. Mitochondrial DNA mutations in late-onset Leigh syndrome. J Neurol. 2018;265:2388–95.
Lee HF, Tsai CR, Chi CS, Lee HJ, Chen CCC. Leigh syndrome: clinical and neuroimaging follow-up. Pediatr Neurol. 2009;40(2):88–93.
Sijens PE, Smit GPA, Rödiger LA, van Spronsen FJ, Oudkerk M, Rodenburg RJ, et al. MR spectroscopy of the brain in Leigh syndrome. Brain Dev. 2008;30(9):579–83.
Acknowledgements
This work was promoted within the European Reference Network (ERN) for Neuromuscular Diseases (M.S, G.C)
Funding
Open access funding provided by Università degli Studi del Piemonte Orientale Amedeo Avogrado within the CRUI-CARE Agreement.
Author information
Authors and Affiliations
Contributions
Patient care: D. Vecchio, G. Strigaro, and L. Mazzini; investigations: Genovese, D. Piga, and M. Sciacco; data curation: E. Cipriano; writing original draft preparation: E. Cipriano and D. Vecchio; review and editing: G. Comi and R. Cantello. All authors have read and agreed to the published version of the manuscript.
Corresponding author
Ethics declarations
Ethics Approval
All procedures performed in studies involving human participants were by the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Consent to Participate
Not applicable
Consent for Publication
Written informed consent for publication was obtained from all individual participants included in the study.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Cipriano, E., Vecchio, D., Mazzini, L. et al. Walking Difficulties and Brainstem Dysfunction: a Case Report of Adult Onset Leigh Syndrome. SN Compr. Clin. Med. 5, 154 (2023). https://doi.org/10.1007/s42399-023-01496-y
Accepted:
Published:
DOI: https://doi.org/10.1007/s42399-023-01496-y